G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALL

Detalles Bibliográficos
Autores principales: Iacobucci, Ilaria, Fukano, Reiji, D. Friske, Jake, Qu, Chunxu, Janke, Laura J., Zhao, Yaqi, Baviskar, Pradyuamna, A. Backhaus, Emily, Chockley, Peter, Seth, Aman, Laird, A. Douglas, Advani, Anjali S., Mullighan, Charles G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198944/
https://www.ncbi.nlm.nih.gov/pubmed/34991158
http://dx.doi.org/10.1182/bloodadvances.2021004854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198944/
https://www.ncbi.nlm.nih.gov/pubmed/34991158
http://dx.doi.org/10.1182/bloodadvances.2021004854

Ejemplares similares